Greenhill & Co.
 | |
| Public company | |
| Traded as | NYSE: GHL |
| Industry | Investment Banking |
| Founded | 1996 |
| Headquarters |
300 Park Avenue (Manhattan) New York City, United States |
Key people |
Robert F. Greenhill (Chairman and Founder) Scott L. Bok (CEO) |
| Products | Investment Banking |
| Revenue |
 $287 million (2013)[1] |
|
$47 million (2013)[1] | |
| Website | www.greenhill.com |
Greenhill is an independent, New York based, investment bank founded in 1996 by Robert F. Greenhill. It is considered one of the most elite and prestigious firms on Wall Street, with a widely respected M&A practice.[2]
The firm provides advice on mergers, acquisitions, restructurings, financings, and capital raisings to leading corporations, partnerships, institutions and governments across a number of industries. Recent clients include Actavis, Alcoa, Fluor Corporation, Gannett, GlaxoSmithKline, London Stock Exchange Group, Safeway, Tesco, Teva, and the US Department of Treasury.[3]
History
Greenhill was established in New York City in 1996 by Robert F. Greenhill, the former President of Morgan Stanley and former Chairman and Chief Executive Officer of Smith Barney. He founded the first M&A group on Wall Street while at Morgan Stanley and became an early pioneer of the industry.[4]
Greenhill has been featured in many prominent assignments since its founding including the $100 billion acquisition of ABN AMRO in 2007, the United States Department of Treasury's divestiture of its $51 billion stake in AIG in 2012, and the $17 billion merger between Northwest Airlines and Delta Air Lines in 2008.[5] The firm was also involved as an adviser to a highly influential group of former Morgan Stanley partners in their successful and controversial bid to have former Morgan Stanley CEO Philip J. Purcell step down in 2005.[6]
Like a number of other independent investment banks, Greenhill has grown by recruiting a significant number of Managing Directors from major investment banks (as well as senior professionals from other institutions).[7] The firm has also expanded globally, opening further offices in North America, Europe, Australasia, Asia and South America.[8]
In May 2004, the firm completed an initial public offering of common stock onto the New York Stock Exchange.[9]
Recent activities
In October 2013, the firm announced that it had opened an office in São Paulo in conjunction with hiring Daniel Wainstein, the former head of Goldman Sachs' Brazilian investment banking business.[10]
In 2014, Greenhill advised on the $25 billion acquisition of Forest Laboratories by Actavis and the $10 billion merger between Safeway and Albertsons.[3] Both transactions were among the ten largest of the year globally.
In January 2015, Greenhill agreed to purchase Cogent Partners, a leading investment bank focused on secondary market advisory for private equity investments.[11]
In July 2015, Greenhill advised Teva Pharmaceuticals on the $40.5 billion acquisition of Allergan plc’s Generics business in one of the largest transactions globally in 2015.[12]
References
- 1 2 http://www.greenhill.com/sites/default/files/Greenhill_2013_Annual_Report.pdf
- ↑ "Greenhill & Co., Inc.|Company Review|Vault.com". Vault. Retrieved 2016-04-02.
- 1 2 "Recent Transactions".
- ↑ Suzanne McGee, Chasing Goldman Sachs (Crown Business, 2010), p52
- ↑ "Recent Transactions".
- ↑ "Blue Blood and Mutiny".
- ↑ http://www.cnbc.com/id/30699636
- ↑ "Global Offices".
- ↑ "Greenhill & Co. files to go public in $86 million deal - Market News - Shares & Markets - Telegraph".
- ↑ Greenhill & Co., Inc. (1 October 2013). "Greenhill to Expand to Brazil with Opening of Sao Paulo Office; Daniel Wainstein to Lead".
- ↑ Sonali Basak (10 February 2015). "Greenhill Climbs on Deal to Buy Cogent in Pension-Advisory Push". Bloomberg.com.
- ↑ Chitra Somayaji; David Wainer (27 July 2015). "Teva Snaps Up Allergan's Generics Arm, Dumping Mylan". Bloomberg.com.